Collectively, despite the limitations due to the low number of patients, these findings indicate that GBM tumors expressing higher KDM5C levels are positively associated with increased HIF1A, suggesting a potential pro-tumorigenic activity of KDM5C in GBM. This evidence concerns the gene KDM5C and glioblastoma.